PL420907A1 - Composition in the form of gel - Google Patents

Composition in the form of gel

Info

Publication number
PL420907A1
PL420907A1 PL420907A PL42090717A PL420907A1 PL 420907 A1 PL420907 A1 PL 420907A1 PL 420907 A PL420907 A PL 420907A PL 42090717 A PL42090717 A PL 42090717A PL 420907 A1 PL420907 A1 PL 420907A1
Authority
PL
Poland
Prior art keywords
composition
subject
application
gel
joint
Prior art date
Application number
PL420907A
Other languages
Polish (pl)
Other versions
PL235088B1 (en
Inventor
Artur WILANDT
Krzysztof Lemke
Jan PROCEK
Original Assignee
Biovico Spolka Z Ograniczona Odpowiedzialnoscia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovico Spolka Z Ograniczona Odpowiedzialnoscia filed Critical Biovico Spolka Z Ograniczona Odpowiedzialnoscia
Priority to PL420907A priority Critical patent/PL235088B1/en
Priority to PCT/PL2018/000028 priority patent/WO2018182436A2/en
Publication of PL420907A1 publication Critical patent/PL420907A1/en
Publication of PL235088B1 publication Critical patent/PL235088B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

Przedmiotem zgłoszenia jest nowa kompozycja zawierająca kwas hialuronowy, fosfolipidy, rozpuszczalne związki krzemu do zastosowania w układzie buforującym. Przedmiotem zgłoszenia jest również zastosowanie kompozycji do leczenia bólu stawów, uszkodzeń stawów/ścięgien, zapaleniu stawów w tym Reumatoidalnego Zapalenia Stawów (RZS), oraz jako induktor kolagenu, wypełniacz kosmetyczny.The subject of the application is a new composition containing hyaluronic acid, phospholipids, soluble silicon compounds for use in a buffering system. The subject of the application is also the use of the composition for the treatment of joint pain, joint / tendon damage, arthritis including Rheumatoid Arthritis (RA), and as a collagen inducer, a cosmetic filler.

PL420907A 2017-03-20 2017-03-20 Composition in the form of gel PL235088B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL420907A PL235088B1 (en) 2017-03-20 2017-03-20 Composition in the form of gel
PCT/PL2018/000028 WO2018182436A2 (en) 2017-03-20 2018-03-20 A composition in the form of a gel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL420907A PL235088B1 (en) 2017-03-20 2017-03-20 Composition in the form of gel

Publications (2)

Publication Number Publication Date
PL420907A1 true PL420907A1 (en) 2018-09-24
PL235088B1 PL235088B1 (en) 2020-05-18

Family

ID=62530522

Family Applications (1)

Application Number Title Priority Date Filing Date
PL420907A PL235088B1 (en) 2017-03-20 2017-03-20 Composition in the form of gel

Country Status (2)

Country Link
PL (1) PL235088B1 (en)
WO (1) WO2018182436A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021121566A1 (en) * 2019-12-17 2021-06-24 Aa Healthcare Sàrl Utilization of a composition comprising organic silica for the improvement of the quality of cartilagenous tissues

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100393322C (en) * 2002-08-16 2008-06-11 电气化学工业株式会社 Separate medical material
US9216164B2 (en) * 2009-07-23 2015-12-22 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
RU2473352C2 (en) * 2011-04-21 2013-01-27 Закрытое акционерное общество "Институт прикладной нанотехнологии" Intra-articular fluid simulator formulation and method for preparing intra-articular fluid additive
US10646574B2 (en) * 2014-07-21 2020-05-12 Board Of Regents, The University Of Texas System Formulations of intraarticular pharmaceutical agents and methods for preparing and using the same

Also Published As

Publication number Publication date
WO2018182436A3 (en) 2018-12-20
PL235088B1 (en) 2020-05-18
WO2018182436A2 (en) 2018-10-04

Similar Documents

Publication Publication Date Title
PH12020500066A1 (en) Carboxamides as modulators of sodium channels
EP4506001A3 (en) SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS
PH12015502792A1 (en) Crystalline bromodomain inhibitors
MX388457B (en) IMIDAZOPIRAZINE INHIBITORS OF BRUTON'S TYROSINE KINASE.
EA201390803A1 (en) Bromodomain inhibitors and their use
MX2019014041A (en) MAGL PYRAZOLIC INHIBITORS.
MX360833B (en) Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use.
BR112017023391A2 (en) "composition, method for preparing a composition and methods for improving skin hydration"
MX378502B (en) BISPECIFIC ANTI-IL-4/ANTI-IL-13 ANTIBODY FORMULATIONS.
MX2015004165A (en) Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and on hydroxyapatite, for therapeutic use.
DK2126049T3 (en) Human cytomegalovirus (hCMV) antibodies
MX2019014042A (en) Pyrazole magl inhibitors.
MX2020007495A (en) Group b adenovirus-containing formulation.
MX2019008544A (en) Novel stable formulation for fxia antibodies.
EA202191686A1 (en) COLLAGEN HYDROLYSATE FOR APPLICATION AGAINST SKIN DISEASES AND INTESTINAL DISEASES
GB201206486D0 (en) Vesicular formulations and uses thereof
EA201891610A1 (en) DERIVATIVES 3- (CARBOXYETHYL) -8-AMINO-2-OXO-1,3-DIAZASPIRO [4.5] DEAN
EA201690659A1 (en) COMPOSITIONS OF AMORPHOUS MAGNESIUM SUBSTITUTE CALCIUM PHOSPHATE AND THEIR APPLICATION
MY199876A (en) Anti-pacap antibody
MY209656A (en) Compositions and methods of enhancing 5-hydroxytryptophan bioavailability
HK1220621A1 (en) Compositions for treatment of xerostomia and for tooth treatment
MX2021003584A (en) FORMULATION FOR USE IN THE TREATMENT OF OSTEOARTHRITIS.
MX2019010218A (en) Pyrazole derivatives as bromodomain inhibitors.
MX2017010277A (en) Cenicriviroc for the treatment of fibrosis.
EA201991395A1 (en) NEW COMPOSITIONS FOR TREATMENT OF JOINT VIOLATIONS